IDEXX LABORATORIES INC
IDXXNASDAQTrading Snapshot
- Day Range
- $555.21 β $567.77
- 52-Week Range
- $500.61 β $769.98
- Volume (shares)
- 351,495
- Avg Volume (shares)
- β
- Shares Outstanding
- 78.8M
- Next Earnings
- 2026-11-02
Fundamentals Snapshot
- Annual Revenue
- $4.30B
- Last Q Revenue
- $1.22B
- P/E Ratio
- 39.5
- P/S Ratio
- 9.7x
- EPS (TTM)
- $14.23
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β2.3%
IDEXX LABORATORIES INC
IDXXAbout IDEXX LABORATORIES INC
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

Gear Up for Idexx (IDXX) Q3 Earnings: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Idexx (IDXX) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics

IDEXX Laboratories, Inc. $IDXX Shares Purchased by Citizens Financial Group Inc. RI
Citizens Financial Group Inc. RI grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 51.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchan

Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings
IDXX heads into Q3 earnings with expected revenue and EPS growth, fueled by CAG Diagnostics momentum, higher testing volumes and software gains.

IDEXX Laboratories, Inc. $IDXX Shares Acquired by Diversify Advisory Services LLC
Diversify Advisory Services LLC lifted its stake in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 39.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exch

Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.